NSE - Delayed Quote INR

Advanced Enzyme Technologies Limited (ADVENZYMES.NS)

Compare
477.45 -0.85 (-0.18%)
At close: 3:29 PM GMT+5:30
Loading Chart for ADVENZYMES.NS
DELL
  • Previous Close 478.30
  • Open 475.55
  • Bid --
  • Ask --
  • Day's Range 468.85 - 497.40
  • 52 Week Range 308.00 - 571.00
  • Volume 293,457
  • Avg. Volume 521,029
  • Market Cap (intraday) 53.418B
  • Beta (5Y Monthly) 0.42
  • PE Ratio (TTM) 38.50
  • EPS (TTM) 12.40
  • Earnings Date Nov 9, 2024
  • Forward Dividend & Yield 5.10 (1.08%)
  • Ex-Dividend Date Jul 18, 2024
  • 1y Target Est 333.00

Advanced Enzyme Technologies Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of enzymes and probiotics in India, Europe, the United States, Asia, and internationally. The company offers enzymes and probiotics-based nutritional supplements for human healthcare and animal nutrition, fruit and vegetable processing, baking, brewing and malting, starch and grain processing, protein modification, yeast processing, dairy and cheese processing, and oils and fats processing, as well as for specialty applications, biofuels, and bio-catalysis. It provides non-food processing enzymes for textile, leather, and pulp and paper processing, as well as detergents and cleaning aids. The company was formerly known as Advanced Biochemicals Limited and changed its name to Advanced Enzyme Technologies Limited in 2005. Advanced Enzyme Technologies Limited was founded in 1957 and is based in Thane, India.

www.advancedenzymes.com

323

Full Time Employees

March 31

Fiscal Year Ends

Recent News: ADVENZYMES.NS

View More

Performance Overview: ADVENZYMES.NS

Trailing total returns as of 11/4/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

ADVENZYMES.NS
28.93%
S&P BSE SENSEX
9.06%

1-Year Return

ADVENZYMES.NS
56.92%
S&P BSE SENSEX
22.40%

3-Year Return

ADVENZYMES.NS
34.91%
S&P BSE SENSEX
31.80%

5-Year Return

ADVENZYMES.NS
162.46%
S&P BSE SENSEX
96.15%

Compare To: ADVENZYMES.NS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ADVENZYMES.NS

View More

Valuation Measures

Annual
As of 11/1/2024
  • Market Cap

    52.94B

  • Enterprise Value

    47.93B

  • Trailing P/E

    38.19

  • Forward P/E

    33.33

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    8.40

  • Price/Book (mrq)

    4.00

  • Enterprise Value/Revenue

    7.60

  • Enterprise Value/EBITDA

    20.53

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    21.97%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    6.31B

  • Net Income Avi to Common (ttm)

    1.39B

  • Diluted EPS (ttm)

    12.40

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    5.29B

  • Total Debt/Equity (mrq)

    3.45%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: ADVENZYMES.NS

View More

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 1.55B
Earnings 341.52M
 

Analyst Price Targets

333.00 Low
333.00 Average
477.45 Current
333.00
 

Company Insights: ADVENZYMES.NS

People Also Watch